Abstract
We have previously used mosaic flies to screen for tumour suppressors or negative regulators of cell proliferation1. The cellular composition of these flies resembles that of cancer patients who are chimaeric individuals carrying a small number of mutated somatic cells. One of the genes we identified is the large tumour suppressor gene, lats (also known as wts), which encodes a putative serine/threonine kinase1,2. Somatic cells mutant for lats undergo extensive proliferation and form large tumours in many tissues in mosaic adults. Homozygous mutants for various lats alleles display a range of developmental defects including embryonic lethality1. Although many tumour suppressors have been identified in Drosophila melanogaster3,4,5,6,7, it is not clear whether these fly genes are directly relevant to tumorigenesis in mammals. Here, we have isolated mammalian homologues of Drosophila lats. Human LATS1 suppresses tumour growth and rescues all developmental defects, including embryonic lethality in flies. In mammalian cells, LATS1 is phosphorylated in a cellâcycleâdependent manner and complexes with CDC2 in early mitosis. LATS1âassociated CDC2 has no mitotic cyclin partner and no kinase activity for histone H1. Furthermore, lats mutant cells in Drosophila abnormally accumulate cyclin A. These biochemical observations indicate that LATS is a novel negative regulator of CDC2/cyclin A, a finding supported by genetic data in Drosophila demonstrating that lats specifically interacts with cdc2 and cyclin A.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Xu, T. et al. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121, 1053â1063 (1995).
Justice, R.W., Zilian, O., Woods, D.F., Noll, M. & Bryant, P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534â546 (1995).
Klämbt, C. et al. The Drosophila melanogaster l(2)gl gene encodes a protein homologous to the cadherin cellâadhesion molecule family. Dev. Biol. 133, 425â436 (1989).
Mahoney, P.A. et al. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 67, 583â868 (1991).
Woods, D. & Bryant, P.J. The Discs Large tumor suppressor gene of Drosophila encodes a guanylated kinase homolog localized at septate junction. Cell 66, 451â 464 (1991).
Boedigheimer, M. & Laughon, A. expended: a gene involved in the control of cell proliferation in imaginal discs. Development 118, 1291â1301 (1993).
Theodosiou, N.A., Zhang, S., Wang, W.Y. & Xu, T. shiva/slimb coordinates wg and dpp expression in the dorsalâventral and anteriorâposterior axes during limb development. Development 125, 3411â3416 ( 1998).
Knehr, M. et al. A critical appraisal of synchronization methods applied to achieve maximal enrichment of HeLa cells in specific cell cycle phases. Exp. Cell Res. 217, 546â553 (1995).
Draetta, G. & Beach, D. Activation of CDC2 protein kinase during mitosis in human cells: cell cycleâdependent phosphorylation and subunit rearrangement. Cell 54, 17â 26 (1988).
Fields, S. & Song, O. A novel genetic system to detect proteinâprotein interactions. Nature 340, 245â 246 (1989).
Finley, R.L. & Brent, R. in DNA Cloning: A Practical Approach: Expression Systems (eds Glover, D.M. & Hames, B.D.) 170â 203 (Oxford, New York, 1994).
Sun, Z. et al. Spk1/Rad53 is regulated by Mec1âdependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev. 10, 395â406 (1996).
Draetta, G. et al. Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell 56, 829â838 (1989).
Solomon, M.J., Glotzer, M., Lee, T.H., Philippe, M. & Kirschner, M.W. Cyclin activation of p34cdc2. Cell 63, 1013â1024 (1990).
Sherr, C.J. Cancer cell cycles. Science 274, 1672â 1677 (1996).
King, R.W., Jackson, P.K. & Kirschner, M.W. Mitosis in transition. Cell 79, 563â571 (1994).
Clegg, N., Whitehead, I., Williams, J., Spiegelman, G. & Grigliatti, T. A developmental and molecular analysis of Cdc2 mutations in Drosophila melanogaster. Genome 36, 676â685 ( 1993).
Toyn, J. & Johnston, L. The Dbf2 and Dbf20 protein kinases of budding yeast are activated after the metaphase to anaphase cell cycle transition. EMBO J. 13, 1103â 1113 (1994).
Millward, T., Cron, P. & Hemmings, B. Molecular cloning and characterization of a conserved nuclear serine (threonine) protein kinase. Proc. Natl Acad. Sci. USA 92, 5022â5026 ( 1995).
Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225â 236 (1995).
Leitina, B., SvetâMoldavsky, G., Tumyan, B. & Zinzar, S. Enormous organâlike growth of transplants of fetal digestive tract. Transplantation 11, 499â 502 (1971).
Bryant, P. in The Genetics and Biology of Drosophila (eds Ashburner, M. & Novitski, E.) PAGES? (Academic Press, New York, 1978).
Michalopoulos, G. & DeFrances, M. Liver regeneration. Science 276, 60â66 (1997).
Wang, J., Chenivesse, X., Henglein, B. & Brechot, C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343, 555â557 (1990).
Keyomarsi, K. & Pardee, A. Redundant cyclin overexpression and gene amplification in breast cancer cell. Proc. Natl Acad. Sci. USA 90, 1112â1116 ( 1993).
Arany, I., Rady, P., Evers, B.M., Tyring, S.K. & Townsend, C.M. Analysis of multiple molecular changes in human endocrine tumors. Surg. Oncol. 3, 153â 159(1994).
St. John, M.A.R. et al. Mice deficient for Lats1 develop soft tissue sarcomas, ovarian tumours and pituitary dysfunction. Nature Genet. 21, 182â186 (1999).
St. John, M.A.R. & Xu, T. Understanding human cancer in a fly? Am. J. Hum. Genet. 61, 1006â1010 (1997).
Xu, T. & Rubin, G.M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117 , 1223â1237 (1993).
Thomas, B.J., Gunning, D.A., Cho, J. & Zipursky, L. Cell cycle progression in the developing Drosophila eye: roughex encodes a novel protein required for the establishment of G1. Cell 77, 1003 â1014 (1994).
Acknowledgements
We thank H. Zhang for advice; T. Grigliatti and C. Lehner for reagents; members of the Xu lab for comments; and W. Yu, T. Ding, X. Fei and K. Sepanek for assistance. W.T. was an Anna Fuller fellow. G.S.T. is an NSF graduate fellow. S.Z. and R.S. are YUF students. M.S.J. is a MSTP student. This work is supported in part by grants from NIH (R01CA69408) and the Patrick and Catherine Weldon Donaghue Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tao, W., Zhang, S., Turenchalk, G. et al. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21, 177â181 (1999). https://doi.org/10.1038/5960
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/5960
This article is cited by
-
Hippo signalling in the liver: role in development, regeneration and disease
Nature Reviews Gastroenterology & Hepatology (2022)
-
SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling
Oncogene (2021)
-
Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing
Journal of Physiology and Biochemistry (2021)
-
Premature polyadenylation of MAGI3 is associated with diminished N6-methyladenosine in its large internal exon
Scientific Reports (2018)
-
Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma
Pathology & Oncology Research (2018)


